morphiceptin has been researched along with Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fichna, J; Janecka, A; Kosson, P; Krajewska, U; Mirowski, M; Rozalski, M; Zalewska-Kaszubska, J | 1 |
| Bakogeorgou, E; Castanas, E; Hatzoglou, A; Ouafik, L; Thermos, K | 1 |
2 other study(ies) available for morphiceptin and Breast Cancer
| Article | Year |
|---|---|
Binding of the new morphiceptin analogs to human MCF-7 breast cancer cells and their effect on growth.
Topics: Animals; Breast Neoplasms; Cell Proliferation; Convulsants; Endorphins; Humans; Ligands; Male; Oligopeptides; Protein Binding; Rats; Rats, Wistar; Receptors, Opioid, mu; Tumor Cells, Cultured | 2004 |
Morphine cross-reacts with somatostatin receptor SSTR2 in the T47D human breast cancer cell line and decreases cell growth.
Topics: Base Sequence; Breast Neoplasms; Cell Division; Endorphins; Female; Hormone Antagonists; Humans; Molecular Sequence Data; Morphine; Narcotics; Octreotide; Receptors, Somatostatin; RNA, Messenger; Somatostatin; Tumor Cells, Cultured | 1995 |